Corporate DisclosureSQURPHARMA
SQURPHARMA Corporate Disclosure — 12 December 2019
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 12 December 2019. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
(Continuation news of SQURPHARMA): the separated operations of various aspects of SFRL is a complex one. Since SPL holds 99.50% of the Paid up Capital of SFRL with only 0.50% being held by the minority shareholders, Board of Directors have recommended for amalgamation under provision of section 228 and 229 of the Companies Act 1994. Reason of merger between Square Herbal and Nutraceuticals Ltd. and Square Pharmaceuticals Ltd. is to reform Square Pharmaceuticals Ltd; (cont. 3)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616aceb25a6b000040057ec9
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.